Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 44 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Advanced breast cancer: diagnosis and treatment : Appendix A: Summary of evidence from surveillance

Cited by National Institute for Health and Care Excellence on 24 Jan 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.